secwatch.observer — SEC 8-K summary
======================================

Issuer:     HCW Biologics Inc. (HCWB)
CIK:        0001828673
Form:       8-K
Filed at:   2026-04-30T23:59:59+00:00
Accession:  0001493152-26-019699
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

HCW Biologics enters $3M in consulting agreements contingent on public offering closing
--------------------------------------------------------------------------------

- $2.5M marketing consulting deal with I.R. Agency for 12 days of news distribution campaigns over 60 days starting May 1, 2026.
- $500K consulting agreement with Bowery Consulting for six-month term covering business strategy, capital raising, and market messaging.
- Both agreements contingent on closing of a public offering via Form S-1 (filed Apr 23, amended Apr 24, 2026); fees paid from offering proceeds.
- Marketing Consultant is not a registered broker/dealer, will not solicit investors, and makes no guarantee of trading volume or stock price.
- Consultant fees are non-refundable under any circumstances, including termination or dissatisfaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226019699/0001493152-26-019699-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1828673/000149315226019699/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-019699

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer